Here, we developed and described a protocol for the detection of CDD using the EMNC assay, which incorporates the use of three different recombinant DNA repair enzymes (APE1, OGG1, and NTH1). The gene discussed is OGG1; the disease is craniodiaphyseal dysplasia.